In addition, it accelerates the development of glomerular injury in diabetes via increased transforming growth factor (TGF)-β1 expression; TGF-β is a key regulator of ECM that triggers the proliferation of mesangial cells in DN. This evidence concerns the gene TGFB1 and liver dysplastic nodule.